These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12408185)

  • 21. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
    Tamai I
    Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse.
    Lu Km; Nishimori H; Nakamura Y; Shima K; Kuwajima M
    Biochem Biophys Res Commun; 1998 Nov; 252(3):590-4. PubMed ID: 9837751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy.
    Lamhonwah AM; Olpin SE; Pollitt RJ; Vianey-Saban C; Divry P; Guffon N; Besley GT; Onizuka R; De Meirleir LJ; Cvitanovic-Sojat L; Baric I; Dionisi-Vici C; Fumic K; Maradin M; Tein I
    Am J Med Genet; 2002 Aug; 111(3):271-84. PubMed ID: 12210323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency.
    Amat di San Filippo C; Wang Y; Longo N
    J Biol Chem; 2003 Nov; 278(48):47776-84. PubMed ID: 14506273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney.
    Tamai I; China K; Sai Y; Kobayashi D; Nezu J; Kawahara E; Tsuji A
    Biochim Biophys Acta; 2001 Jun; 1512(2):273-84. PubMed ID: 11406104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
    Ohashi R; Tamai I; Nezu Ji J; Nikaido H; Hashimoto N; Oku A; Sai Y; Shimane M; Tsuji A
    Mol Pharmacol; 2001 Feb; 59(2):358-66. PubMed ID: 11160873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLC22A5 mutations in a patient with systemic primary carnitine deficiency: the first Korean case confirmed by biochemical and molecular investigation.
    Yoon YA; Lee DH; Ki CS; Lee SY; Kim JW; Lee YW; Park HD
    Ann Clin Lab Sci; 2012; 42(4):424-8. PubMed ID: 23090741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.
    Friedrich A; Prasad PD; Freyer D; Ganapathy V; Brust P
    Brain Res; 2003 Apr; 968(1):69-79. PubMed ID: 12644265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype-phenotype correlation in primary carnitine deficiency.
    Rose EC; di San Filippo CA; Ndukwe Erlingsson UC; Ardon O; Pasquali M; Longo N
    Hum Mutat; 2012 Jan; 33(1):118-23. PubMed ID: 21922592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GFP-Human high-affinity carnitine transporter OCTN2 protein: subcellular localization and functional restoration of carnitine uptake in mutant cell lines with the carnitine transporter defect.
    Lamhonwah AM; Tein I
    Biochem Biophys Res Commun; 1999 Nov; 264(3):909-14. PubMed ID: 10544029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A founder mutation (R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients.
    Tang NL; Hwu WL; Chan RT; Law LK; Fung LM; Zhang WM
    Hum Mutat; 2002 Sep; 20(3):232. PubMed ID: 12204000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management.
    Magoulas PL; El-Hattab AW
    Orphanet J Rare Dis; 2012 Sep; 7():68. PubMed ID: 22989098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiency.
    Filippo CA; Ardon O; Longo N
    Biochim Biophys Acta; 2011 Mar; 1812(3):312-20. PubMed ID: 21126579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficiency of the carnitine transporter (OCTN2) with partial N-acetylglutamate synthase (NAGS) deficiency.
    Hwu WL; Chien YH; Tang NL; Law LK; Lin CY; Lee NC
    J Inherit Metab Dis; 2007 Oct; 30(5):816. PubMed ID: 17703373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants.
    Vijay S; Patterson A; Olpin S; Henderson MJ; Clark S; Day C; Savill G; Walter JH
    J Inherit Metab Dis; 2006 Oct; 29(5):627-30. PubMed ID: 16865412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine residues affecting sodium stimulation of carnitine transport in the OCTN2 carnitine/organic cation transporter.
    Amat di San Filippo C; Longo N
    J Biol Chem; 2004 Feb; 279(8):7247-53. PubMed ID: 14665638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency.
    Koizumi A; Nozaki J; Ohura T; Kayo T; Wada Y; Nezu J; Ohashi R; Tamai I; Shoji Y; Takada G; Kibira S; Matsuishi T; Tsuji A
    Hum Mol Genet; 1999 Nov; 8(12):2247-54. PubMed ID: 10545605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency.
    Cederbaum SD; Koo-McCoy S; Tein I; Hsu BY; Ganguly A; Vilain E; Dipple K; Cvitanovic-Sojat L; Stanley C
    Mol Genet Metab; 2002 Nov; 77(3):195-201. PubMed ID: 12409266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological rescue of carnitine transport in primary carnitine deficiency.
    Amat di San Filippo C; Pasquali M; Longo N
    Hum Mutat; 2006 Jun; 27(6):513-23. PubMed ID: 16652335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects.
    El-Hattab AW; Li FY; Shen J; Powell BR; Bawle EV; Adams DJ; Wahl E; Kobori JA; Graham B; Scaglia F; Wong LJ
    Genet Med; 2010 Jan; 12(1):19-24. PubMed ID: 20027113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.